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In recent studies, we have shown that Pseudomonas aeruginosa strains that are acutely cytotoxic in vitro
damage the lung epithelium in vivo. Genetic analysis indicated that the factor responsible for acute cytotoxicity
was controlled by ExsA and therefore was part of the exoenzyme S regulon. The specific virulence determinant
responsible for epithelial damage in vivo and cytotoxicity in vitro was subsequently mapped to the exoU locus.
The present studies are focused on a genetic characterization of the exoU locus. Northern blot analyses and
complementation experiments indicated that a region downstream of exoU was expressed and that the expres-
sion of this region corresponded to increased ExoU secretion. DNA sequence analysis of a region downstream
of exoU identified several potential coding regions. One of these open reading frames, SpcU (specific Pseudo-
monas chaperone for ExoU), encoded a small 15-kDa acidic protein (137 amino acids [pI 4.4]) that possessed
a leucine-rich motif associated with the Syc family of cytosolic chaperones for the Yersinia Yops. T7 expression
analysis and nickel chromatography of histidine-tagged proteins indicated that ExoU and SpcU associated as
a noncovalent complex when coexpressed in Escherichia coli. The association of ExoU and SpcU required amino
acids 3 to 123 of ExoU. In P. aeruginosa, ExoU and SpcU are coordinately expressed as an operon that is
controlled at the transcriptional level by ExsA.
Pseudomonas aeruginosa is an opportunistic nosocomial
pathogen involved in septicemia and/or severe pneumonia in a
diverse patient population that includes burn victims, cystic
fibrosis patients, and immunocompromised individuals. The
numerous virulence factors produced by P. aeruginosa include
a group of antihost or effector proteins that are secreted by a
type III or contact-dependent secretion pathway (7, 40). The
components of the P. aeruginosa pathway include over 20 gene
products predicted to make up the type III apparatus and at
least four proteins that have been implicated in the transloca-
tion of effector proteins (reviewed in reference 7). Transloca-
tion is defined as the process by which the bacterium transfers
effectors directly into the host cell cytoplasm and is considered
to represent a specialized intoxication mechanism (14, 16, 19,
27, 30). Because the P. aeruginosa type III system has been
recently discovered, most of the functional characteristics at-
tributed to these proteins are based on the high level of ho-
mology with proteins encoded by the Yersinia virulence plas-
mid pYV. The P. aeruginosa type III secretion apparatus,
translocation proteins, and effectors are coordinately con-
trolled by a common transcriptional activator, ExsA, and are
collectively referred to as members of the exoenzyme S regulon
(7, 8).
Proteins that are unique to the exoenzyme S regulon include
a group of secretion substrates that serve as effectors or anti-
host proteins. These proteins include ExoS, ExoT (7, 39),
ExoY (42), and ExoU (5). ExoS and ExoT are ADP-ribosyl-
transferases that covalently modify several eukaryotic proteins.
The primary substrates include members of the small GTP-
binding H- and K-ras protein families that serve as regulators
of host cell growth and differentiation. The expression of ExoS
and ExoT enzymatic activity is absolutely dependent on a eu-
karyotic cofactor, FAS (factor activating exoenzyme S). FAS is
a member of the 14-3-3 family of cofactors that serve as reg-
ulators of eukaryotic enzyme activities (11). ExoT is relatively
inactive (0.2%) when compared to the ADP-ribosyltransferase
activity exhibited by ExoS (39). ExoS has been shown to pos-
sess cytotoxic activity, to disrupt Ras-mediated signal transduc-
tion pathways in eukaryotic cells, to covalently modify Ras in
vivo, and to cause changes in cytoskeletal structure (2, 9, 12, 23,
25). ExoY is a recently described adenylate cyclase secreted by
the P. aeruginosa type III system. Translocation of ExoY has
been demonstrated, because cells infected with an ExoY-pro-
ducing P. aeruginosa strain accumulate supraphysiological lev-
els of cyclic AMP (42). Similar to ExoS and ExoT, ExoY
requires a eukaryotic cofactor for the stimulation of adenylate
cyclase activity. The cofactor stimulating ExoY activity has not
been identified, but appears to be distinct from calmodulin
(42). The most cytotoxic product of the P. aeruginosa type III
pathway appears to be ExoU. ExoU (5) or PepA (15) was
discovered because of the acute cytotoxic reaction observed
when certain strains of P. aeruginosa were cocultured with
MDCK cells. ExoU production is correlated with lung injury in
an acute infection model in mice (5). Unlike ExoS, ExoT, or
ExoY, an ExoU-associated enzymatic activity has not been
identified, and the mechanism of ExoU-mediated acute cyto-
toxicity has not been defined.
To determine the minimal region of the ExoU locus re-
quired for expression and cytotoxicity, we performed a deletion
analysis. Preliminary data suggested that a region downstream
of the exoU open reading frame (ORF) was required for max-
imal ExoU secretion from P. aeruginosa. These data were rem-
iniscent of the results observed when mutations are introduced
in the Yersinia Syc loci. The Syc proteins are small cytosolic
chaperones that bind their cognate Yop effector proteins (4,
32) before or during secretion from the bacterium (6, 35, 36).
In this article, we report the observation that SpcU (specific
Pseudomonas chaperone for ExoU) affects the extracellular
levels and/or secretion of ExoU. SpcU shares several of the
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common structural properties reported for the cytosolic chap-
erones of Yersinia (37). SpcU is predicted to encode a small-
molecular-mass (14.9-kDa) protein with an acidic pI (4.4) and
a conserved C-terminal leucine motif. We show that histidine-
tagged recombinant SpcU and ExoU associate in a noncova-
lent complex that requires an amino-terminal domain within
ExoU. exoU and spcU are encoded within the same mRNA and
form an operon.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used in this study are listed in Table 1. Escherichia coli TG1 was used
as a host strain for M13 bacteriophage propagation (22). For genetic manipula-
tions, Pseudomonas strains were cultivated in Luria-Bertani (LB) broth and
plated on Vogel-Bonner medium (34). E. coli DH5a and BL21(DE3) were
cultured in LB broth or agar. For ExoU production, P. aeruginosa strains were
cultivated in a deferrated dialysate of Trypticase soy broth containing 10 mM
nitrilotriacetic acid as previously described (17). Bacteria containing plasmids
were grown in the presence of the appropriate antibiotic(s) at a final concentra-
tion of 100 mg of ampicillin, 34 mg of chloramphenicol (E. coli), 400 mg of
carbenicillin, and 100 mg of tetracycline (P. aeruginosa) per ml.
DNA methods. Plasmid DNA was isolated by standard alkaline lysis proce-
dures (22) or by the use of Qiagen spin or Midi-Prep columns (Qiagen, Inc.,
Santa Clarita, Calif.). DNA fragments were purified from agarose gels by using
a Qiaquick gel extraction kit (Qiagen, Inc.). Transformation of E. coli and P.
aeruginosa was performed as previously described (22, 24). PCRs were per-
formed with Deep Vent polymerase (New England Biolabs, Beverly, Mass.) in an
Amplitron II thermocycler (Thermolyne, Barnstead, Dubuque, Iowa). A 2-min
preincubation at 98°C was followed by 30 cycles consisting of a 1-min denatur-
ation step; annealing for 1 min at variable temperature, depending on the primer;
and extension at 72°C for 1 min. A 5-min extension step at 72°C at the end of the
cycling period was performed. All primers were obtained from Operon Tech-
nologies, Inc. (Alameda, Calif.) and the location of relevant primers for reverse
transcriptase-PCR (RT-PCR) is shown in Fig. 4A.
Plasmid construction. For expression and purification of recombinant ExoU
and/or SpcU in E. coli, pET16b and pET23b vectors were used (Novagen).
pET16b and pET23b each encode histidine tags (10 and 6 amino acids, respec-
tively) which were cloned in frame with either ExoU (N-terminal tag) or SpcU
(C-terminal tag). DNA fragments containing the coding regions for exoU and
spcU were either excised as restriction fragments from subclones of pUCPexoU-
(Bam6.5), pUCPexoUEcoRV, and pUC18exoU656 or as fragments isolated from
PCRs. After being subcloned in M13 vectors, all amplified fragments were
subjected to nucleotide sequence analysis with an ALF automated sequencer and
reagents (Pharmacia, Piscataway, N.J.) to confirm the fidelity of the Deep Vent
polymerase.
For expression and complementation studies in P. aeruginosa, plasmids con-
taining exoU on a 6.5-kb BamHI fragment [pUCPexoU(Bam6.5)], exoU and spcU
on a 2.8-kb EcoRV fragment (pUCPexoUEcoRV), or the exoU ORF alone
(pUCPNexoU) were constructed in the E. coli-P. aeruginosa shuttle vector
pUCP19 (28). Fragments were obtained by standard techniques through partial
restriction endonuclease digestion or PCR amplification. All constructs were
transcribed by the native exoU promoter region, which is controlled by the
transcriptional activator ExsA.
To construct a nonpolar mutation in exoU without disrupting spcU, a flanking
region upstream and including the start codon of ExoU was cloned in the gene
replacement vector, pNOT19, as a HindIII-NsiI fragment. A tetracycline car-
tridge was inserted into the HindIII site to serve as a selectable marker for
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant properties or genotypea Source orreference
Strains
E. coli
BL21(DE3) hsd-5 gal (l cIts857 indl Sam7 nin5 lacUV5-T7 gene1) 33
BL21(DE3) pLysS pLysS (Cmr) 33
DH5a supE44 DlacU169 (f80 lacZDM15) hsdR17 recA1 endA1 gyrA96 22
thi-1 relA1
SM10 thi thr leu tonA lacY supE recA::Rp4-2Tc::Mu Km 39
P. aeruginosa
PA103 Wild type, exoU1 exoT1 exoS 5, 8
PAK Wild type, exoU exoT1 exoS1 5, 8
PA103DexoU exoU nonpolar mutant This study
PA103exoU::Tn5Tc exoU polar mutant, mini-Tn5Tc insertion 5
Plasmids
pUC18, pUC19 Wild type, Apr 22
pUCP19 Wild type, E. coli-P. aeruginosa shuttle vector, Apr 28
pUC18exoU656 Contains the exoU promoter and 656 aa of ExoU This study
pET16b N-terminal His tag fusion expression vector, Apr Novagen
pET23b C-terminal His tag fusion expression vector, Apr Novagen
pET16bDEcoRI Deletion of EcoRI site of pET16b J. T. Barbieri
pETexoS pET16bDEcoRI encoding His-ExoS 20
pETexoU656 pET16bDEcoRI encoding 656 aa of His-ExoU This study
pETexoU pET16bDEcoRI encoding 687 aa of His-ExoU, This study
pETexoUspcU pET16bDEcoRI encoding His-ExoU and SpcU This study
pET23exoUspcU pET23b encoding ExoU and SpcU-His This study
pET23D3–123exoUspcU pET23b encoding an in-frame deletion (D3–123) of ExoU and SpcU-His This study
pUCPNexoU pUCP19 encoding only ExoU with the native promoter and stop sequences This study
pUCPexoUEcoRV pUCP19 containing exoUspcU, as a 2.8-kb EcoRV fragment This study
pUCPexoU(Bam6.5) pUCP19 containing a 6.5-kb BamHI fragment with exoU and flanking
downstream sequences
5
pNOT19 Allelic replacement vector 29
pNOTexoU pNOT19 containing a 6.5-kb fragment with exoU and additional
downstream sequences
This study
pNOTDexoU pNOT19 containing an in-frame deletion of aa 3–674 of ExoU This study
pMOB3 pHSS21; Kmr Cmr sacBR oriT as a NotI cartridge 29
pMOBDexoU pNOTDexoU with the NotI cartridge from pMOB3 This study
a aa, amino acids.
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transconjugants. This marker was located outside the region needed for homol-
ogous recombination into the chromosome. To provide downstream flanking
sequences, a region was amplified that included the last 14 codons of ExoU and
738 bp of downstream DNA. Primers used for amplification contained 59 NsiI
and 39 EcoRI sites to ligate into the 59NsiI site of exoU and a 39 EcoRI site of the
vector. This strategy deleted 672 codons of ExoU and provided an in-frame stop
codon for the predicted 13-amino-acid peptide. The deletion was confirmed by
nucleotide sequence analysis. The NotI mobilization cartridge (29) was added as
a NotI fragment to complete the construct. Conjugation, selection of transcon-
jugants, and resolution of plasmid sequences from the chromosome were per-
formed as previously described (29, 39). The chromosomal exoU deletion in
strain PA103 (PA103DexoU) was confirmed by Southern blot analysis with both
internal and downstream probes (data not shown).
Complementation of PA103exoU::Tn5Tc or PA103DexoU. Complementation
plasmids were transformed into PA103exoU::Tn5Tc or PA103DexoU by the
MgCl2 method (24). Transformants were grown under inducing conditions for
maximal expression of ExoU and SpcU (5, 8). Cultures were harvested at the
stationary phase and normalized to identical optical density readings at 540 nm.
Cellular lysates and concentrated supernatant fractions were prepared as previ-
ously described (8).
Nucleotide sequence analysis. DNA was subcloned in M13mp18 and -19 ac-
cording to standard protocols (22), and DNA sequencing was performed with an
ALF automated sequencer (Pharmacia) and fluoresceinated primers (Operon
Technologies). Analysis of sequences was performed with Genetics Computer
Group software (Madison, Wis.).
RNA isolation, RT-PCR, and Northern blot analysis. Total RNA was isolated
from PA103, PA103exoU::Tn5Tc, and PA103exoU::Tn5Tc/pUCPexoU(Bam6.5)
from cultures grown under inducing conditions (13). Northern blot analysis was
performed as previously described (41) with a 2-kb EcoRV restriction fragment
and a 466-bp XhoI restriction fragment to detect messages specific for exoU and
downstream loci, respectively.
To map the 39 end of the exoU locus mRNA, a combination of primers were
used with RT-PCR amplification of cDNA. P. aeruginosa PA103 (exoU1) and
PAK (exoU) were grown under inducing conditions, and total RNA was isolated
from mid-log-phase bacterial cultures (13). Random primers (50 ng) and Super-
script II RT (Life Technologies) were used for first-strand cDNA synthesis
according to the manufacturer’s recommendations. Ten percent of the first-
strand reaction mixture was used as a template for specific amplification with
primers R1-4 and 59 (Fig. 4A).
Expression, purification, and quantitation of recombinant proteins in E. coli.
Plasmids containing histidine-tagged versions of ExoU and/or SpcU were trans-
formed into BL21(DE3) pLysS. After overnight growth, strains were diluted
50-fold into 800 ml of LB broth with ampicillin and chloramphenicol. After 2 h
of growth at 30°C, expression of recombinant proteins was induced with 0.75 mM
IPTG (isopropyl-b-D-thiogalactopyranoside), and incubation was continued for
an additional 2 h. Cellular extracts were prepared as described previously (39),
filtered, and loaded onto a 3-ml nickel-nitrilotriacetic acid-agarose column (Qia-
gen). For the pET16b series (10-histidine amino-terminal leader), the column
was washed with 30 ml of binding buffer (wash 1) followed by binding buffer
containing 60 mM imidazole (wash 2). Bound proteins were eluted with binding
buffer containing 0.5 M imidazole and collected as 2-ml fractions. For the
pET23b series (a six-histidine carboxyl-terminal tag), wash 2 contained 25 mM
imidazole, and bound proteins were eluted with 250 mM imidazole.
Denaturing chromatography was performed to determine the binding charac-
teristics of histidine-tagged ExoU or SpcU. Histidine-tagged proteins were first
isolated under nondenaturing conditions by nickel chromatography as described
above. The peak fraction containing the eluted tagged protein and other asso-
ciated peptide(s) was diluted in a solution of urea to obtain a final concentration
of 6 M. The fraction was further dialyzed in either binding buffer (His-ExoU) or
phosphate-buffered saline (SpcU-His) containing 6 M urea. Samples were sub-
sequently reapplied to the nickel column in the presence of urea. The column
was washed and eluted with buffers containing 6 M urea. Fractions were col-
lected, and samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) (13.5% polyacrylamide) and Western blot analyses
(8). Blots were probed with rabbit anti-ExoU or monoclonal anti-histidine tag
antibodies (Qiagen) with a secondary rabbit anti immunoglobulin G (IgG) (Sig-
ma Chemical Co.). Bound IgG was detected with 125I-protein A and autoradiog-
raphy. Proteins were quantitated with the bicinchonic acid protein kit (Pierce,
Rockford, Ill.) or by densitometry of Coomassie-stained polyacrylamide gels with
bovine serum albumin as a standard.
Nucleotide sequence accession number. The accession number for the nucle-
otide sequence reported for spcU is U97065.
RESULTS
Complementation of P. aeruginosa PA103exoU::Tn5Tc. Pre-
vious studies had shown that the PA103exoU::Tn5Tc mutant
strain, when complemented in trans with a plasmid containing
exoU on a 6.5-kb BamHI fragment, produced extracellular
ExoU, was cytotoxic in vitro, and resulted in lung injury in vivo
(5). To map the minimal region required for ExoU expression
and secretion, we constructed 39 deletions of pUCPexoU-
(Bam6.5) (Table 1 and Fig. 4A) and performed complemen-
tation analyses with PA103exoU::Tn5Tc. Comparisons of
equivalent amounts of total protein from the supernatants and
lysates of complemented strains indicated that the amount of
extracellular ExoU varied with the length of flanking down-
stream sequence (Fig. 1A and B, lanes 2 to 4, SUP) in a specific
manner. The levels of ExoU produced in the lysates appeared
similar in all complemented strains (Fig. 1A and B, lanes 2 to
4, LYS). These data suggested that sequences downstream of
exoU were not required for synthesis but appeared essential for
maximal expression of ExoU in P. aeruginosa supernatants.
One hypothesis to account for these observations is that an
ORF(s) located downstream of exoU was involved in ExoU
secretion. To test this hypothesis, total RNA was isolated from
strains cultured under inducing conditions for ExoU expres-
sion and subjected to Northern blot analysis. Two probes were
used to detect mRNA. One probe corresponded to the exoU
promoter region and a majority of the ORF, and the second
probe was located immediately downstream (103 bp) of the
exoU stop codon. Both probes hybridized to a 2.4-kb message
(data not shown). These data indicated that the exoU mRNA
was approximately 400 bp larger than expected and may con-
tain another ORF.
Nucleotide sequence analysis of the exoU downstream re-
gion. Downstream sequences flanking exoU were subjected to
restriction mapping analysis and subcloned into M13 vectors
for sequencing. The G1C content of the region downstream of
exoU was significantly lower (56%) than that of the P. aerugi-
nosa genome sequences (67%), which is consistent with the
lower observed G1C content of exoU (5). Translation of the
nucleotide sequence identified three overlapping ORFs encod-
FIG. 1. Complementation of PA103exoU::Tn5Tc. (A) SDS-polyacrylamide
gel (11% acrylamide), stained with Coomassie blue R250, of protein profiles of
P. aeruginosa PA103exoU::Tn5Tc (a polar insertion within exoU, host strain)
containing different plasmid constructs of the ExoU locus. All strains were grown
under inducing conditions for expression of the exoenzyme S regulon. Equivalent
amounts (normalized to the culture optical density at 540 nm) of either extra-
cellular fractions (supernatant [SUP]) or lysate (LYS) preparations were loaded
in each lane. Lanes: 1, P. aeruginosa PA103exoU::Tn5Tc; 2, PA103exoU::Tn5Tc
complemented in trans with pUCPexoU(Bam 6.5); 3, the host strain with
pUCPexoUEcoRV; and 4, the host strain with pUCPNexoU. The positions of
other type III-secreted products of the exoenzyme S regulon are shown by
asterisks in panel A (in descending order, ExoT, PopB, PopD, PopN, and PcrV).
(B) Western Blot analysis of a duplicate gel probed with polyclonal anti-ExoU
antibodies. The positions of ExoU (arrow) and molecular weight (MW) stan-
dards (left [thousands]) are indicated.
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ing predicted proteins with molecular masses of 14.9, 8.0, and
4.6 kDa. The first ORF possessed a start codon that over-
lapped the stop codon of exoU and a putative ribosome binding
site (located 5 bp upstream of the start codon). This ORF, now
termed spcU (specific Pseudomonas chaperone for ExoU), en-
coded a protein of 137 amino acids, with a predicted molecular
mass of 14.9 kDa and an acidic pI of 4.4. The physical prop-
erties of SpcU are consistent with the characteristics of type III
cytosolic chaperones (35, 37). We performed BESTFIT and
Pile-Up alignments (Fig. 2) with Orf1 of P. aeruginosa (postu-
lated chaperone for ExoS and ExoT), SycE (chaperone for
YopE), SycH (chaperone for YopH), and SycT (chaperone for
YopT). Pile-up analysis (Fig. 2) indicated that the C-terminal
region of SpcU aligned with a common leucine-rich motif
found within the chaperone family, as first defined by Cornelis
and coworkers (18, 35, 37).
Complementation of a nonpolar exoU mutation in strain
PA103. To determine if SpcU was required for ExoU secretion,
a nonpolar deletion in exoU was introduced into the chromo-
some of strain PA103 by standard allelic replacement proce-
dures (29, 39). This strain, PA103DexoU, no longer produced
ExoU (Fig. 3, lanes 2 and 3) but was able to synthesize and
secrete other proteins of the exoenzyme S regulon (PopB,
PopD, PopN, PcrV, and ExoT). Southern blot analysis using
internal and downstream probes for the exoU locus confirmed
the deletion of exoU and demonstrated that the region down-
stream of exoU was intact (data not shown). The complemen-
tation analysis was repeated with the series of deletion plas-
mids used in the initial complementation experiments of the
polar mutant PA103exoU::Tn5Tc. No differences were de-
tected in the amount of extracellular ExoU when PA103DexoU
was complemented with constructs that differed in terms of the
length of included downstream sequences (Fig. 3). These data
are consistent with the hypothesis that an ORF located down-
stream of exoU affects the extracellular levels and/or secretion
of ExoU. The ability of ExoU to mediate cytotoxicity was also
assessed in the nonpolar mutant. In tissue culture assays using
trypan blue staining to detect dead cells, PA103DexoU was
noncytotoxic (data not shown). The cytotoxic phenotype was
restored with a plasmid containing only the exoU ORF,
pUCPNexoU (data not shown). This analysis indicates that
ExoU expression alone is responsible for the observed acute
cytotoxic phenotype of strain PA103.
The exoU locus is organized as an operon. Our initial results
with Northern blot analysis suggested that the exoU locus en-
coded an mRNA containing both exoU and spcU coding re-
gions. Since Northern blot analysis is relatively insensitive and
it is difficult to accurately interpret the size of the message, we
used RT-PCR to confirm the operon organization of the exoU
locus. PCR primers were designed to differentiate between one
unique or two separate transcripts (Fig. 4A). Total RNA was
isolated from a strain containing (PA103) and a strain not
containing (PAK) the exoU locus (5). Amplified products were
detected only from RNA isolated from PA103 and only in
reaction mixtures containing RT. These controls show that the
cDNA products detected were specific to exoU mRNA. The
size of the detected cDNA products was consistent with the
calculated fragments based on a single mRNA encoding both
exoU and spcU (Fig. 4B). We conclude that the exoU locus is
organized as an operon encoding exoU and spcU.
Association of recombinant ExoU and SpcU. To investigate
whether ExoU would bind to the postulated SpcU chaperone,
exoU and/or spcU was expressed from pET16b in E. coli (Fig.
4A). When the exoU ORF was expressed (pETexoU) and sub-
jected to nickel chromatography, His-ExoU was specifically
eluted by imidazole (Fig. 5A). An identical experiment was
repeated with pETexoUspcU, and the peak fractions between
the two experiments were compared by SDS-PAGE (Fig. 5B).
When spcU was also present in the construct, a protein with the
predicted molecular mass of SpcU coeluted with His-ExoU
(Fig. 5B, lane 1). To test for nonspecific binding to the nickel
columns, pT7-7exoUspcU was constructed. In this construct,
ExoU and SpcU were coexpressed as native proteins without
histidine tags. After chromatography, neither protein bound to
the nickel columns, eliminating possible nonspecific associa-
tions of ExoU and SpcU with the matrix (data not shown).
These preliminary results suggested that SpcU bound nonco-
valently to ExoU. To confirm the identity of the SpcU ORF,
the 14-kDa band, isolated from peak fractions containing His-
FIG. 2. Pileup alignment of the leucine repeat motif from Syc and Syc-like
chaperones. Amino acids 84 to 115 of SpcU were aligned to amino acids 85 to
116 of Orf1 (putative chaperone for ExoS or ExoT) (41), amino acids 87 to 118
of SycE (37), amino acids 89 to 120 of SycH (35), and amino acids 81 to 112 of
SycT (18). Common amino acids that conform to the consensus sequence are
presented in shaded boxes. A consensus sequence, which includes SpcU as part
of the alignment, is shown. A consensus sequence, as determined by Iriarte and
Cornelis (18), which includes a leucine-rich motif, is indicated for comparison.
FIG. 3. Complementation of PA103DexoU. (A) SDS-PAGE analysis (11%
acrylamide; Coomassie-stained gel) of equivalent amounts of extracellular pro-
teins from P. aeruginosa strains grown under inducing conditions for the exoen-
zyme S regulon. Lanes: 1, strain PA103; 2, PA103DexoU (a nonpolar deletion in
exoU); 3, PA103DexoU containing the vector control plasmid pUCP19; 4,
PA103DexoUpUCPNexoU; 5, PA103DexoUpUCPexoUEcoRV; 6, PA103DexoU
pUCPexoU(Bam 6.5). The positions of other type III-secreted products of the
exoenzyme S regulon are shown by asterisks in panel A (in descending order,
ExoT, PopB, PopD, PopN, and PcrV). (B) Western blot of a duplicate gel
probed with polyclonal anti-ExoU antibodies. The positions of ExoU (arrow)
and molecular weight (MW) standards (left [thousands]) are indicated.
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FIG. 4. ExoU locus constructs and amplification of the exoU-spcU transcript by RT-PCR. (A) Schematic representation of the location of the exoU and spcU ORFs
within different plasmid constructs used in complementation analyses in P. aeruginosa (constructs, lines 1 to 3), protein expression and purification in E. coli (constructs,
lines 4 to 7), and mapping of the mRNA 39 end (line 8). Double slash marks indicate regions that are not drawn to scale. The chromosomal insertion of the polar Tn5
insertion within the 59 coding region of exoU is illustrated by an inverted triangle (line 1). Corresponding constructs include pUCPexoU(Bam6.5) (line 1),
pUCPexoUEcoRV (line 2), pUCPNexoU (line 3), pETexoUspcU (line 4), pETexoU (line 5), pET23exoUspcU (line 6), and pET23D3–123exoUspcU (line 7). N, NsiI; E,
EcoRV; B, BamHI. An inverted V in the construct on line 7 represents the deletion of amino acids 3 to 123 of ExoU. Line 8, map of the ExoU locus with the
approximate locations of primers used for PCR amplification. Total RNAs from P. aeruginosa strains PA103 (exoU1) and PAK (exoU) were used for the first-strand
cDNA synthesis in the presence (1) or absence (2) of Superscript II RT. RT-PCR was performed as described in Materials and Methods. (B) Products of the RT-PCRs
were analyzed on a 1.2% agarose gel. PA103 (exoU1) and PAK (exoU) strains are indicated over the brackets, and the primer pairs used for each reaction are
underlined. M, molecular weight markers. 1 and 2, reaction mixtures containing (1) or not containing (2) RT.
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ExoU (Fig. 5B, lane 1), was transferred to Immobilon polyvi-
nylidene difluoride and subjected to N-terminal amino acid
sequence analysis. The amino terminus (MIDTXLAQXGLR)
of the 14-kDa protein was identical (12 amino acids) to the
predicted amino terminus of SpcU.
Association of recombinant ExoU and SpcU under denatur-
ing conditions. If the association between ExoU and SpcU was
noncovalent, then chromatography under denaturing condi-
tions should dissociate this interaction. The peak elution frac-
tion from an affinity purification of pETexoUspcU was col-
lected in a solution of urea (6 M final concentration). After
dialysis to remove imidazole, this fraction was subjected to a
second nickel chromatography in the presence of 6 M urea.
Under these conditions, SpcU was predominantly detected in
the flowthrough and wash fractions (Fig. 6, lanes FT, wash 1).
Some His-ExoU (approximately 12% of the total His-ExoU
load) was detected in these fractions, but the majority (88%) of
the protein was eluted with imidazole (Fig. 6A, lanes 1 to 3).
Western blot analysis with an antiserum specific for ExoU
confirmed the approximate values derived from densitometry
of Coomassie-stained gels (Fig. 6B). These data indicate that
the association between His-ExoU and SpcU is noncovalent and
can be disrupted by exposure to the chaotropic reagent, urea.
The converse experiment was performed to determine if a
C-terminal, polyhistidine-tagged SpcU (SpcU-His) could asso-
ciate with ExoU under native and denaturing nickel chroma-
tography conditions. The exoUspcU operon was constructed
such that the stop codon of spcU was eliminated to fit in frame
with the C-terminal polyhistidine tag of pET23b. Under native
chromatography conditions, SpcU-His and ExoU coeluted
(Fig. 7A, B, and C, load lanes). The elution fractions from
native chromatography were dialyzed to remove imidazole,
brought to 6 M urea, and loaded onto a second nickel column
equilibrated with 6 M urea. Under these binding conditions,
ExoU was detected in the flowthrough and wash fractions (Fig.
7A and B, lanes FT and wash 1), while SpcU was detected in
the fractions eluted with imidazole (Fig. 7A, lanes 1 to 5). To
provide a more sensitive assay for ExoU and SpcU-His, the
same fractions were subjected to Western blot analysis with
either a rabbit antiserum to ExoU or a monoclonal antibody
specific for the histidine-tagged portion of the fusion protein
(Fig. 7B and C). These data clearly show that under denaturing
conditions, ExoU is present in the load, flowthrough, and wash
1 fractions, while SpcU-His is present in the load and the
eluted fractions. Taken together, the results from native and
denaturing nickel chromatography, with both His-ExoU and
SpcU-His, indicate that ExoU and SpcU specifically associate
in a noncovalent complex.
Chaperone binding domain of ExoU. Since many of the type
III chaperones bind to the amino-terminal domain of their
cognate protein (21, 30, 31), we constructed an in-frame ami-
no-terminal deletion (residues 3 to 123) within ExoU and in-
vestigated whether this recombinant derivative interacted with
SpcU. Expression of both SpcU-His and D3–123ExoU was
detected in the load fraction from an extract prepared from
pET23D3–123exoUspcU (Fig. 8A, load lane). Based on densi-
tometry of a Coomassie-stained gel, approximately 90% of
D3–123ExoU was detected in the flowthrough and wash 1
fractions. SpcU-His was eluted from this column by using im-
idazole (Fig. 8A, lanes 2 and 3). Western blot analysis with an
antiserum to ExoU (Fig. 8B) or a monoclonal antibody to the
histidine tag (Fig. 8C) confirmed the results obtained with the
protein profile shown in Fig. 8A. We concluded that amino
acids 3 to 123 of ExoU are involved in the interaction between
ExoU and SpcU.
DISCUSSION
Our initial studies of exoU focused on the expression of the
protein relative to the cytotoxicity and lung injury caused by P.
FIG. 6. Denaturing nickel chromatography of His-ExoU. An N-terminal his-
tidine-tagged ExoU construct also encoding an untagged version of SpcU
(pETexoUspcU) was expressed in E. coli BL21(DE3) pLysS. The peak eluate
fraction from a chromatography performed under nondenaturing conditions
(Fig. 5B, lane 1) was collected in a urea solution (final concentration of 6 M).
After dialysis to eliminate imidazole, the denatured sample was loaded onto a
nickel column equilibrated in urea. (A) SDS-PAGE analysis (13.5% polyacryl-
amide) of the column fractions which include the load, flowthrough (FT), wash
fractions 1 and 2, and elution fractions (in the presence of a high concentration
of imidazole) 1 to 5. (B) Western blot analysis of a duplicate gel probed with
polyclonal antiserum specific for ExoU. Bound IgG was detected by 125I-protein
A. His-ExoU and SpcU (arrows) and molecular weight (MW) standards (left
[thousands]) are indicated.
FIG. 5. Nickel chromatography, under native conditions, of recombinant
amino-terminally-tagged ExoU. (A) SDS-PAGE (13.5% polyacrylamide stained
with Coomassie blue R250) analysis of the cell lysate from host strain E. coli
BL21(DE3) pLysS with pETexoU (N-terminal 10-histidine tag). Protein profiles
of the cell lysate are shown as the material loaded onto a nickel column (Load),
the flowthrough from the column (FT), wash fractions 1 and 2, and the elution
fractions 1 to 5 in the presence of high concentrations of imidazole. The arrow
denotes the position of His-ExoU. (B) SDS-PAGE analysis of peak eluate
fractions from nickel chromatography of two expression constructs. Lane 1 con-
tains the peak eluate fraction from an expression experiment using the
pETexoUspcU construct to produce recombinant protein (His-ExoU and SpcU).
Lane 2 contains a similar fraction from the expression of pETexoU (His-ExoU).
Molecular weight (MW) standards (left [thousands]) and recombinant proteins
(arrows) are indicated.
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aeruginosa (5). Previous analyses indicated that the exoU locus
was part of a larger DNA element that may encode other
virulence determinants. We noted that the G1C content of the
region was significantly lower than that of the P. aeruginosa
genome and mapped 59 insertion-like sequences (5). With
these data, we initiated a complementation analysis to further
characterize the locus. The complementation profile of a non-
polar chromosomal exoU deletion mutant confirmed the pres-
ence of a coding region, located downstream of exoU, which
appeared to influence the amount of extracellular ExoU de-
tected. Nucleotide sequence analysis of the region immediately
downstream of exoU identified three ORFs, only one of which,
SpcU, possessed the common physical characteristics and
leucine motif of type III chaperones (35, 37). The identity of
the SpcU ORF was confirmed by amino-terminal sequence
analysis of a 14-kDa protein that coeluted with His-ExoU.
Binding studies indicated that SpcU associated specifically with
full-length ExoU but did not associate with an amino-terminal
deletion (D3–123) derivative of ExoU. The binding of SpcU
and ExoU was noncovalent and could be disrupted by using 6
M urea. These experiments, however, do not exclude the pos-
sibility that an E. coli-derived protein may mediate the interaction
between ExoU and SpcU. Taken together, our results support the
hypothesis that SpcU functions as a chaperone for ExoU.
Although the chaperone predicted to bind ExoS and possi-
bly ExoT (Orf1) was reported previously, this is the first report
of the binding of a P. aeruginosa type III-encoded chaperone to
a secretion substrate. The postulated functions of the type III
chaperones are based on the results of studies investigating the
mechanism of Yop secretion in Yersinia. Functions that have
been attributed to type III chaperones include increasing the
cytosolic stability of the Yops (3, 10), preventing the premature
association of the Yops with the translocator proteins YopB
and YopD (38), targeting of the Yop effectors to the secretion
and/or translocation apparatus (3, 19, 21), and preventing cy-
tosolic Yop aggregation (38). Recombinant ExoU, when pro-
duced as an amino-terminal histidine-tagged protein, appears
to form fibular structures in the absence of SpcU (data not
shown). These data suggest that SpcU may function in part by
keeping ExoU from aggregating in the P. aeruginosa cytoplasm
before the type III apparatus secretes it. ExoU appears to be
synthesized as a relatively stable intracellular product, because
complementation of the polar insertion in PA103exoU::Tn5Tc
with plasmids containing or not containing spcU resulted in
similar amounts of protein in bacterial lysates. Interestingly, in
the absence of SpcU, small amounts of ExoU were detected in
the supernatant fraction. These results suggest that a small
amount of protein may be released upon lysis, that SpcU is not
absolutely required for secretion, or that another chaperone
may be able to partially substitute for the SpcU function. The
former hypothesis is consistent with the observation that YopE
and YopH appear to have two distinct secretion domains, only
one of which involves the chaperone binding domain (3, 21, 30,
38). The most likely candidate for a functional SpcU substitute
may be the putative chaperone for ExoS or ExoT, Orf1 (41).
Although strain PA103 does not possess exoS, hybridization
analysis indicates that this strain possesses a chromosomal
copy of orfl (data not shown). We observed in earlier work that
ExoS, ExoT, and ExoU all possessed an identical amino-ter-
minal sequence (six amino acids) and suggested that this motif
may be related to secretion (5). Domain mapping experiments
also determined that the first 99 amino acids of ExoS were
required for secretion and that this domain contained a region
that encoded the aggregation properties of the molecule (20,
41). When ExoS and ExoU are aligned, a region encompassing
37 amino-terminal amino acids (18 to 53, ExoS; and 4 to 40,
ExoU) demonstrates 31% identity with two areas of conserved
residues. These data indicate that there may be some cross talk
between the Orf1 and SpcU chaperones, perhaps as a protec-
FIG. 7. Denaturing nickel chromatography of SpcU-His. A C-terminal six-
histidine-tagged SpcU-His fusion construct also encoding an untagged version of
ExoU was expressed from E. coli BL21(DE3) pET23exoUspcU. The eluate frac-
tions from a native chromatography of the cell lysate were pooled, dialyzed to
eliminate imidazole, brought to 6 M urea, and loaded onto a nickel column
equilibrated in urea. (A) SDS-PAGE (13.5% polyacrylamide) analysis of the
protein profiles of the different fractions: load, flowthrough (FT), wash fractions
(wash 1 and 2), and elution fractions 1 to 5. (B) Western blot analysis of a
duplicate gel (as in panel A) probed with polyclonal antiserum specific for ExoU.
(C) Western blot analysis of a duplicate gel (as in panel A) probed with a primary
monoclonal antibody specific for the histidine tag and a secondary rabbit anti-
mouse IgG. Bound IgG was detected in blots B and C by using 125I-protein A.
Arrows on the right indicate the migration of ExoU and SpcU-His. The molec-
ular weight (MW) markers are indicated on the left (thousands).
FIG. 8. Amino acids 3 to 123 of ExoU are required to bind to SpcU-His. The
cell lysate from E. coli BL21(DE3)pLysS pET23D3–123exoUspcU was subjected
to nickel affinity chromatography under native conditions. This construct en-
codes an amino-terminal deletion derivative of ExoU and SpcU-His. (A) SDS-
PAGE analysis (13.5% polyacrylamide) of the protein profiles of the different
fractions: load, flowthrough (FT), wash fractions 1 and 2, and elution fractions 1
to 5. (B) Western blot analysis of a duplicate gel (as shown in panel A) probed
with polyclonal antiserum specific for ExoU. (C) Western blot analysis of a
duplicate gel (as shown in panel A) probed with a primary monoclonal antibody
specific for the histidine tag and a secondary rabbit anti-mouse IgG. Bound IgG
was detected by 125I-protein A. Arrows on the right indicate the migration of
D3–123ExoU and SpcU-His. The molecular weight (MW) markers are indicated
on the left (thousands).
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tive mechanism to prevent toxic buildup of intracellular type
III secretion aggregates.
The exoU locus appears to consist of exoU and spcU and
probably does not include further sequences. The sizes of the
message on Northern blots obtained with both exoU and spcU
probes were identical and appear to correspond to the additive
length of both coding regions. RT-PCR analysis demonstrated
that the two coding regions were physically associated on the
same message. It is unclear at this time why the addition of
further downstream sequences appears to enhance ExoU pro-
duction. Other factors could be encoded downstream of exoU
or spcU that either may stabilize ExoU or the operon transcript
or may enhance exoU translation. There is some precedence
for the hypothesis that a separately encoded product may en-
hance exoU translation. Genetic studies of exoS expression
indicate that the regulatory protein ExsC is involved in either
ExoS stability or translation (13). As in Yersinia, these obser-
vations suggest that together transcription, translation, and
secretion may be important parameters in expression of the P.
aeruginosa type III effector proteins (1, 26).
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